Asset Acquisition (Details Narrative) - Sequence LifeScience Inc [Member] - USD ($) $ in Thousands		12 Months Ended
	Oct. 09, 2024	Dec. 31, 2024
Asset Acquisition [Line Items]
Consideration for assets	$ 5,500
Upfront payment	1,000
Monthly milestone payments	4,000
Prior payment to related party	$ 500
Net sales percentage	20.00%
Purchase price contingent consideration	$ 4,000
Milestone payments		$ 135